Heron Therapeutics Inc vs Pinterest Inc — how do they compare? Heron Therapeutics Inc trades at $0.36 (market cap $68.01M), while Pinterest Inc trades at $20.76 (market cap $11.63B). The key difference: Pinterest Inc is far larger — about 171× Heron Therapeutics Inc's market cap, and Pinterest Inc is trading nearer its 52-week high, Heron Therapeutics Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Heron Therapeutics Inc for 35 Days and Pinterest Inc for 85 Days on average.
| HRTX | PINS | |
|---|---|---|
Market Cap | $68.01M | $11.63B |
Volume | 1,891,941 | 12,792,940 |
Sector | Health | Media |
52-Week High | $1.49 | $35.24 |
52-Week Low | $0.27 | $15.42 |
Typical Hold Time | 35 Days | 85 Days |
Enterprise Value | $174.75M | $11.55B |
Signals from Pluang's Aura AI — not financial advice
Heron Therapeutics (HRTX) is trading at $0.39, up 17.58% today, with a bullish technical outlook from moving averages but mixed signals from oscillators. The company maintains strong gross margins of 70.07% but continues to report net losses, with Q2 2026 missing both EPS and revenue expectations. Analyst sentiment remains overwhelmingly positive with 89% buy ratings despite recent earnings disappointments and negative profitability metrics.
While analyst consensus is strongly bullish, HRTX faces significant fundamental challenges including consistent net losses, negative ROE of -78.72%, and cash flow concerns. The stock's current momentum appears driven by technical factors rather than improving fundamentals, creating a high-risk investment profile that requires careful monitoring of upcoming Q3 earnings and revenue stabilization efforts.
Pinterest (PINS) trades at $20.31, up 1.4% today, with a bullish technical signal and strong earnings beats in recent quarters. Revenue growth accelerated to $4.22 billion in 2025, with a net income margin of 9.87%, while analyst consensus is a Buy with a $27.93 price target. Recent news highlights its undervaluation and new Visual Search Ads launch, though insider selling and cash flow volatility present mixed signals.
The outlook is positive given robust fundamentals and growth potential, but risks include competitive pressures and reliance on ad revenue. Upside is supported by earnings momentum and international monetization, yet investors should monitor cash flow trends and market sentiment shifts for sustained gains.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →Pinterest is an online product and idea discovery platform that helps users gather ideas on everything from recipes to cook to destinations to travel to. Founded in 2010, the platform consists of a largely female audience, at roughly two thirds of its more than 365 million monthly active users. The company generates revenue by selling digital ads and is now rolling out more in-platform e-commerce features.
Read more on PINS →